News for Cannabics Pharmaceuticals Inc. (CNBX)

According to Straits Research, “The global cancer cachexia market size was worth USD 2.47 billion in 2022, and it is estimated to reach an expected value...

CNBX Pharmaceuticals Inc. (OTCQB: CNBX) has acquired a controlling interest in TaGeza Biopharmaceuticals Ltd. The TaGeza research team remains committed to the company, and co-founder professor Benjamin Dekel (MD, PhD) will continue to serve as the company's chief scient

REHOVOT, Israel and BETHESDA, Md., Sept. 29, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. , a global leader in the development of cancer related cannabinoid-based medicine, announced... | September 29, 2022

REHOVOT, Israel and BETHESDA, MD., Sept. 28, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. , a global leader in the development of cancer related cannabinoid-based medicine, announced today... | September 28, 2022

Read Cannabics Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Significant Decrease in Short Interest at ETF Daily News

/PRNewswire/ -- The newly published report titled "Global Cannabinoid Derived Pharmaceutical Market – By Trends, Industry Competition Analysis, Pipeline...

TEL AVIV, Israel and BETHESDA, Md., Oct. 21, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. , a global leader in the development of cancer related cannabinoid-based... | October 21, 2021

TEL AVIV, Israel and BETHESDA, Md., Oct. 19, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. , a global leader in the development of cancer related cannabinoid-based... | October 19, 2021

Cannabics Pharmaceuticals Inc. (OTC:CNBX), a global leader in the deve...

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

TEL AVIV, Israel and BETHESDA, Maryland, July 20, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. , a global leader in the development of cancer related cannabinoid-based... | July 20, 2021

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

MIAMI, June 17, 2021 (GLOBE NEWSWIRE) -- Crosswind Renewable Energy Corp. dba Community Redevelopment (OTC: CWNR) ("the Company"), a community oriented real